Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO ...

A biopsy would later reveal the mass to be a yolk sac tumor, which would begin the toughest stretch of Grossi’s life. But he didn’t go through it alone.

Instil expects to initiate a phase 1 trial of ‘2510 as monotherapy for patients with relapsed/refractory solid tumors before the end of 2025.

The post Netanyahu: We removed ‘tumors’ of Iran’s nuclear and missile threats, but monitoring needed so they don’t reemerge appeared first on The Times of Israel.